Results 141 to 150 of about 87,091 (254)

Aminoquinoline antimalarial drugs and drug candidates.

open access: yes, 2015
Aminoquinoline antimalarial drugs and drug candidates.
Christiane Deregnaucourt (815024)   +7 more
core   +1 more source

Severe Plasmodium vivax Malaria Presenting With Circulatory Shock and Coagulation Abnormalities: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Severe Plasmodium vivax malaria may cause vasopressor‐requiring shock, profound thrombocytopenia, jaundice, coagulation activation, and transient cardiopulmonary abnormalities. Early parasite confirmation and close monitoring for evolving organ dysfunction are essential.
Bushra Majid   +8 more
wiley   +1 more source

Hydroxychloroquine‐Associated Renal Phospholipidosis: A Forgotten Complication of a Common Drug

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Hydroxychloroquine (HCQ) treatment in systemic lupus erythematosus can induce drug‐induced phospholipidosis mimicking Fabry disease. A 32‐year‐old woman with lupus nephritis developed podocyte “zebra bodies” on electron microscopy. Normal lyso‐Gb3 excluded Fabry disease, confirming HCQ toxicity.
Yu‐Chien Tsao, Chun‐Hsin Wu
wiley   +1 more source

Evaluación in vivo de la actividad antimalárica de 25 plantas provenientes de una Reserva de Conservación Biológica de Costa Rica In vivo evaluation of the antimalarial activity of 25 plants from a Biological Conservation Reserve of Costa Rica

open access: yesRevista Chilena de Historia Natural, 2011
Se realizó una evaluación in vivo de la actividad antimalárica de las hojas, flores, frutos, corteza y raíz de 25 plantas de la Reserva Biológica Alberto Manuel Brenes (REBAMB), situada en San Ramón, Alajuela, Costa Rica.
MISAEL CHINCHILLA-CARMONA   +7 more
doaj  

Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with Berzosertib

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1315-1325, November 2026.
Repurposing drugs whose clinical safety has been established offers a valuable approach to reduce the cost and time associated with the development of new drugs for malaria. Here, we investigate the potential to repurpose the anticancer kinase inhibitor berzosertib for the treatment of malaria, by assessing whether a predicted efficacious human dose ...
Devasha Redhi   +5 more
wiley   +1 more source

From Prediction to Decision Making: PBPK and QSP as Regulatory‐Grade NAMs

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1195-1207, November 2026.
New approach methodologies (NAMs) encompass a diverse and rapidly evolving set of experimental and computational tools designed to generate human‐relevant mechanistic data for use in drug development and regulatory decision making. Experimental NAMs provide insights into drug disposition, pharmacological activity, and disease biology that are difficult
Karen Rowland Yeo, Piet H. van der Graaf
wiley   +1 more source

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis

open access: yes
Background: Therapeutic efcacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potentially preclude/pre-empt the detection of subsequent recrudescence of ...
Bassat Orellana, Quique   +1 more
core  

HPLC‐DAD‐ESI‐MS/MS Analysis and Evaluation of Antioxidant and Antidiabetic Activities of Vachellia tortilis subsp. raddiana (Savi) Kyal. & Boatwr. Extracts

open access: yesFood Science &Nutrition, Volume 14, Issue 11, November 2026.
The study investigated the phytochemical composition of Vachellia tortilis subsp. raddiana leaf and gum extracts using HPLC‐DAD‐ESI‐MS/MS and evaluated their antioxidant and antidiabetic activities. The leaf extract showed a higher content of phenolic and flavonoid compounds and exhibited promising antioxidant and α‐amylase inhibitory activities ...
Douae Taha   +7 more
wiley   +1 more source

Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria

open access: yesMedicinal Research Reviews, Volume 46, Issue 6, Page 1477-1498, November 2026.
ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy